Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway
Wen-Ke Wang1, Qing-Hua Lu, Jia-Ning Zhang
1The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Insights
High mobility group box 1 protein (HMGB1) inhibition protects against high glucose-induced cardiomyocyte apoptosis. HMGB1 reduction decreases cell death by down-regulating extracellular signal-regulated kinase (ERK) and Ets-1 signaling pathways.
Area of Science:
- Cardiology
- Molecular Biology
- Diabetology
Background:
- Diabetic cardiomyopathy involves cardiomyocyte apoptosis.
- High mobility group box 1 protein (HMGB1) expression increases in diabetic conditions.
- The mechanism of high glucose (HG)-induced cardiomyocyte apoptosis is not fully understood.
Purpose of the Study:
- To investigate the role of HMGB1 in high glucose (HG)-induced cardiomyocyte apoptosis.
- To elucidate the molecular mechanism underlying HG-induced cardiomyocyte apoptosis.
Main Methods:
- Primary cardiomyocytes were treated with HG and HMGB1 was inhibited using short-hairpin RNA.
- Caspase-3 activation and the ratio of Bcl2-associated X protein to B-cell lymphoma/leukemia-2 (bax/bcl-2) were measured.
- Extracellular signal-regulated kinase 1/2 (ERK1/2) and Ets-1 activation were assessed in vitro and in vivo using streptozotocin-induced diabetic mice.
Main Results:
- HG treatment increased cardiomyocyte apoptosis and HMGB1 levels.
- HMGB1 inhibition reduced HG-induced apoptosis by decreasing caspase-3 activation and altering the bax/bcl-2 ratio.
- HMGB1 inhibition attenuated HG-induced activation of Ets-1 via the ERK1/2 pathway.
- Inhibition of Ets-1 also decreased HG-induced cardiomyocyte apoptosis.
- Similar protective effects of HMGB1 inhibition were observed in diabetic mice, reducing myocardial apoptosis and ERK/Ets-1 activation.
Conclusions:
- HMGB1 plays a critical role in high glucose-induced cardiomyocyte apoptosis.
- Inhibition of HMGB1 may offer a therapeutic strategy against hyperglycaemia-induced cardiac damage.
- The protective mechanism involves the down-regulation of ERK-dependent Ets-1 activation.
Abstract:
Apoptosis is a key event involved in diabetic cardiomyopathy. The expression of high mobility group box 1 protein (HMGB1) is up-regulated in diabetic mice. However, the molecular mechanism of high glucose (HG)-induced cardiomyocyte apoptosis remains obscure. We aimed to determine the role of HMGB1 in HG-induced apoptosis of cardiomyocytes. Treating neonatal primary cardiomyocytes with HG increased cell apoptosis, which was accompanied by elevated levels of HMGB1. Inhibition of HMGB1 by short-hairpin RNA significantly decreased HG-induced cell apoptosis by reducing caspase-3 activation and ratio of Bcl2-associated X protein to B-cell lymphoma/leukemia-2 (bax/bcl-2). Furthermore, HG activated E26 transformation-specific sequence-1 (Ets-1), and HMGB1 inhibition attenuated HG-induced activation of Ets-1 via extracellular signal-regulated kinase 1/2 (ERK1/2) signalling. In addition, inhibition of Ets-1 significantly decreased HG-induced cardiomyocyte apoptosis. Similar results were observed in streptozotocin-treated diabetic mice. Inhibition of HMGB1 by short-hairpin RNA markedly decreased myocardial cell apoptosis and activation of ERK and Ets-1 in diabetic mice. In conclusion, inhibition of HMGB1 may protect against hyperglycaemia-induced cardiomyocyte apoptosis by down-regulating ERK-dependent activation of Ets-1.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
Hyperglycemia
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways
Hyperosmolar Hyperglycemic State
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...